Scarica l'app Stockscreener
0.005
17.76%
-0.00108
Petros Pharmaceuticals Inc Borsa (PTPI) Ultime notizie
Petros Pharmaceuticals Stock Price Forecast. Should You Buy PTPI? - StockInvest.us
India Erectile Dysfunction Drugs Market Outlook, 2033 - grandviewresearch.com
Petros net loss narrows 40.06% to $1.94 million in 1H FY26; SG&A drops 38.2% to $2.02 million - Bitget
Biofrontera Inc. (BFRI) stock price, news, quote and history - Yahoo Finance Singapore
Petros Pharmaceuticals, Inc. Revenue Breakdown – OTC:PTPI - TradingView
Galera Therapeutics, Inc. (GRTXD) Stock Price, News, Quote & History - Yahoo Finance
QTREX Quantum Ltd. (QTEX) stock price, news, quote and history - Yahoo Finance UK
Pasithea Therapeutics Corp. (KTTA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Pasithea Therapeutics Corp. (KTTA) stock price, news, quote and history - Yahoo Finance UK
If You Invested $1,000 in Pharmadrug Inc (LMLLF) - Stock Titan
If You Invested $1,000 in Resonate Blends Inc (KOAN) - Stock Titan
Pliant Therapeutics, Inc. Files Form 8-K with SEC Detailing Company Information and NASDAQ Listing - Minichart
Price to sales forward of Petros Pharmaceuticals, Inc. – OTC:PTPI - TradingView
Enterprise value to EBITDA forward of Petros Pharmaceuticals, Inc. – OTC:PTPI - TradingView
Petros Pharmaceuticals Inc (PTPI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
INDEXPLUS Trust Series 2003-1 June 2026 Distribution Report: $1.13M Interest Distributed, Principal Balance Unchanged – Minichart - Minichart
Petros Pharmaceuticals Appoints New Chief Accounting Officer - The Globe and Mail
Petros Pharmaceuticals, Inc. Announces Principal Financial Officer Changes, Effective June 18, 2026 - marketscreener.com
Petros Pharmaceuticals, Inc. Announces Executive Changes, Effective June 18, 2026 - marketscreener.com
Petros Pharmaceuticals Inc (PTPI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Petros Pharmaceuticals Inc (PTPI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Petros Pharmaceuticals Inc (PTPI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Petros Pharmaceuticals Inc (PTPI) Institutional Confidence - TradingKey
Petros Pharmaceuticals Inc (PTPI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Petros Pharmaceuticals Inc (PTPI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Petros Pharmaceuticals Inc (PTPI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Petros Pharmaceuticals Inc (PTPI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Indonesia Erectile Dysfunction Drugs Market Size & Outlook, 2033 - grandviewresearch.com
Petros Pharmaceuticals Grants Targeted Equity Awards to Leadership - The Globe and Mail
Petros Pharmaceuticals, Inc. 8-K SEC Filing June 5, 2026 – Company Details, Address, and Emerging Growth Status - Minichart
Petros grants restricted shares to Joshua Silverman, Bruce Bernstein, Fady Boctor and Wayne Walker - TradingView
Number of shareholders of Petros Pharmaceuticals, Inc. – OTC:PTPI - TradingView
TradingKey - TradingKey
Petros Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Gilead Sciences Q1 2026 Financial Report: Key Highlights, Financial Statements & Risk Factors - Minichart
Petros Pharma Stock Plunges To Record Low On 1-For-25 Reverse Split, But Retail Optimism Lingers - MSN
Petros Pharmaceuticals Transitions to Healthcare Technology with Proprietary Rx-to-OTC SaaS and SaMD Platform Targeting Self-Care Market 36 - Minichart
Petros Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Petros Pharmaceuticals (PTPI) details tech pivot, default fallout and cash strain - Stock Titan
Petros Pharmaceuticals 2025 10-K: Net income $1.91M; continuing ops loss $(4.50)M - TradingView
Petros Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Death Cross: Can Petros Pharmaceuticals Inc expand its profit margins2026 Earnings Surprises & Growth Focused Entry Point Reports - baoquankhu1.vn
Rate Cut: Can Petros Pharmaceuticals Inc expand its profit margins2026 WrapUp & Technical Confirmation Trade Alerts - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Published on: 2026-04-07 04:40:22 - baoquankhu1.vn
Strategy Inc (STRC) Reports 2026 Bitcoin Holdings, Financial Highlights, and Trading Information on NASDAQ - Minichart
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Petros Pharmaceuticals Delays Annual 10-K Filing - TipRanks
Petros Pharmaceuticals (NASDAQ: PTPI) notifies SEC of delayed 2025 10-K filing - Stock Titan
Buybacks Report: Can Petros Pharmaceuticals Inc lead its sector in growthMarket Sentiment Summary & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Chipmakers Recap: Can Petros Pharmaceuticals Inc lead its sector in growth2026 Setups & Momentum Based Trading Ideas - baoquankhu1.vn
Nasdaq Moves: How does Petros Pharmaceuticals Inc perform in inflationary periods2026 Earnings Impact & Accurate Technical Buy Alerts - baoquankhu1.vn
Wall Street Recap: How does Petros Pharmaceuticals Inc perform in inflationary periods2026 Update & Reliable Intraday Trade Plans - baoquankhu1.vn
LYRA Stock Price and Chart — OTC:LYRA - TradingView
HYCO1, PETROS and PJ Energy Services Announce Strategic Collaboration to Advance CO₂ Utilization and Low-Carbon Development in Sarawak - PR Newswire
Petros Pharmaceuticals Grants Significant RSUs to Key Leaders - TipRanks
Petros Pharmaceuticals Inc (NASDAQ: PTPI) Share Price, PTPI Stock News, PTPI Share Price & Updates - Kalkine
CLSDQ Stock Price and Chart — OTC:CLSDQ - TradingView
Petros Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
2.01%
1.17%
Capitalizzazione:
|
Volume (24 ore):